Home » Newsletters » BioWorld

BioWorld

April 8, 1994

View Archived Issues

HYBRIDON OK'D FOR GEM 91 TRIAL

APPOINTMENTS AND ADVANCEMENTS

TARGETED GENETICS LICENSES AAV TECHNOLOGIES

AGENNIX PRODUCING COMMERCIALLY VIABLE LACTOFERRIN

SEPRACOR SPINOFF NETS $13M IN IPO

POLICY REVIEW CONTINUES ON GENETICALLY-ENGINEERED FOOD

TEXAS BIOTECH INTENDS TO BUY IPI

VIVUS IPO NETS $28M

WHY MEMORY LOSS IN ALZHEIMER'S PRECEDES TELLTALE AMYLOID PLAQUES

FDA APPROVES THALIDOMIDE TRIALS